Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Dow
Colorcon
AstraZeneca
Merck

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Semuloparin sodium

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Semuloparin sodium?

Semuloparin sodium is an investigational drug.

There have been 9 clinical trials for Semuloparin sodium. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2008.

The most common disease conditions in clinical trials are Venous Thromboembolism, Thromboembolism, and Hip Fractures. The leading clinical trial sponsors are Sanofi and [disabled in preview].

Recent Clinical Trials for Semuloparin sodium
TitleSponsorPhase
Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous LineSanofiPhase 2
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted MobilitySanofiPhase 3
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement SurgerySanofiPhase 3

See all Semuloparin sodium clinical trials

Clinical Trial Summary for Semuloparin sodium

Top disease conditions for Semuloparin sodium
Top clinical trial sponsors for Semuloparin sodium

See all Semuloparin sodium clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Baxter
Medtronic
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.